Endothelin receptor antagonism by tezosentan attenuates lung injury induced by aortic ischemia-reperfusion

Annals of Vascular Surgery
Ilker KirisNilgün Kapucuoğlu

Abstract

Tezosentan is a novel dual endothelin receptor antagonist. The purpose of this study was to examine the effect of tezosentan on lung injury induced by abdominal aortic ischemia-reperfusion (IR) in rats. Thirty-two Wistar-albino rats were randomized into four groups (eight per group) as follows: control group (sham laparotomy), aortic IR group (120 min ischemia and 120 min reperfusion), aortic IR + tezosentan group (a bolus intravenous injection of 10 mg/kg tezosentan before ischemia plus continuous intravenous infusion of 1 mg/kg/hr tezosentan during 120 min ischemia and 120 min reperfusion), and control + tezosentan. Blood and lung tissue samples were obtained for biochemical analysis. Protein concentrations in bronchoalveolar lavage fluid and lung wet/dry weight ratios were measured. A histological evaluation was also done. Aortic IR significantly increased (p < 0.05 vs. control group) and tezosentan significantly decreased (p < 0.05 vs. aortic IR group) the plasma level of tumor necrosis factor-alpha; lung tissue levels of malondialdehyde, catalase, and myleperoxidase; and protein concentration in bronchoalveolar lavage fluid and lung wet/dry weight ratio. Histological evaluation showed that tezosentan attenuated the morphol...Continue Reading

References

Feb 1, 1991·Circulation·T F Lüscher
Apr 1, 1994·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J NakanoK Ito
Mar 30, 1994·Biochemical and Biophysical Research Communications·T FukurodaM Nishikibe
Nov 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R E CatalánG Díaz
Jul 1, 1997·Journal of the American Society of Nephrology : JASN·S M KrauseS D Kivlighn
Feb 8, 2000·The International Journal of Biochemistry & Cell Biology·M J BoscoeM H Yacoub
Mar 9, 2000·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R PararajasingamR D Sayers
May 22, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M JoyceD J Bouchier-Hayes
Jun 20, 2001·American Journal of Hypertension·C F Krieglstein, D N Granger
Jan 7, 2003·Archives of Surgery·Conor J ShieldsH Paul Redmond
Apr 16, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Jussi M TikkanenKarl B Lemström
Aug 7, 2004·The Tohoku Journal of Experimental Medicine·Huseyin OkutanNamik Delibas
Jan 29, 2005·The Journal of Thoracic and Cardiovascular Surgery·Paul W M FedakChristopher M Feindel
Jul 1, 2005·Critical Care : the Official Journal of the Critical Care Forum·Vladimir KuklinLars Bjertnaes
Jan 25, 2006·Chemico-biological Interactions·M ValkoM Mazur
Jan 1, 1993·Mediators of Inflammation·E HelsetZ S Konopski

❮ Previous
Next ❯

Citations

May 24, 2011·Pharmacological Reports : PR·Aleksandra PiechotaAnna Goraca
Oct 28, 2015·Critical Care : the Official Journal of the Critical Care Forum·Zhengwen XiaoAndrew W Kirkpatrick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.